RadNet Inc

RadNet, Inc. is the largest operator of outpatient diagnostic imaging services and related solutions in the U.S. Shares rose on quarterly results that exceeded expectations, reflecting strong volume trends, and raised 2025 guidance. Revenue grew 8.4% and EBITDA rose 12.3%, beating consensus by 2% and 6%, respectively, supported by total imaging volume growth of 4.9%. Same-store advanced imaging growth accelerated 300 basis points sequentially to 6.6%, while routine imaging increased 1.9%. Adjusted EBITDA margin reached 16.4%. Management cited positives such as an expected 3.3% Medicare rate hike in 2026, expanded MRI and ultrasound capacity through AI-enabled software upgrades, and a strong de novo pipeline.

RadNet, Inc. rose after reporting strong same-store growth in its outpatient diagnostic imaging centers, indicating robust operational performance. The increase in customer spend from biotechnology and pharmaceutical clients is turning up, suggesting a positive trend in revenue generation. The company is well-positioned to capitalize on the growing demand for diagnostic imaging services, which is expected to drive further growth in the coming quarters.

During the quarter, we bought shares of RadNet, Inc., the largest owner and operator of fixed-site, freestanding diagnostic imaging centers in the U.S., with 399 locations. RadNet is benefiting from several secular growth trends. The aging population is driving increased demand for diagnostic imaging services. Payors are steering volume to less costly outpatient providers like RadNet, away from higher cost hospitals. New technology is driving higher demand for more advanced imaging modalities like MRI, CT, and PET, all of which generate higher revenue and margin per procedure for RadNet. Additionally, RadNet is well positioned to lead the transformation of the radiology field with AI and radiology software products, which can grow 30% per year and scale at very high incremental margins.

During the quarter, we bought shares of RadNet, Inc., the largest owner and operator of fixed-site, freestanding diagnostic imaging centers in the U.S., with 399 locations. RadNet is benefiting from several secular growth trends. The aging population is driving increased demand for diagnostic imaging services. Payors are steering volume to less costly outpatient providers like RadNet, away from higher cost hospitals. New technology is driving higher demand for more advanced imaging modalities like MRI, CT, and PET, all of which generate higher revenue and margin per procedure for RadNet. Additionally, RadNet is well positioned to lead the transformation of the radiology field with AI and radiology software products, which can grow 30% per year and scale at very high incremental margins.

During the quarter, we bought shares of RadNet, Inc., the largest owner and operator of fixed-site, freestanding diagnostic imaging centers in the U.S., with 399 locations. RadNet is benefiting from several secular growth trends. The aging population is driving increased demand for diagnostic imaging services. Payors are steering volume to less costly outpatient providers like RadNet, away from higher cost hospitals. New technology is driving higher demand for more advanced imaging modalities like MRI, CT, and PET, all of which generate higher revenue and margin per procedure for RadNet. We think RadNet is well positioned to lead the transformation of the radiology field with AI and radiology software products.